Utilizing social media data for pharmacovigilance: A review

Journal of Biomedical Informatics

Volumn 54, Issue , 2015, Pages 202-212

  Sarker, Abeed ^a   Ginn, Rachel ^a   Nikfarjam, Azadeh ^a   O'Connor, Karen ^a   Smith, Karen ^c   Jayaraman, Swetha ^b   Upadhaya, Tejaswi ^b   Gonzalez, Graciela ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c REGIS UNIVERSITY   (United States)

Author keywords

Adverse drug reaction; Pharmacovigilance; Social media

Indexed keywords

MEDICAL INFORMATICS; SEARCH ENGINES; SOCIAL NETWORKING (ONLINE); SUPERVISED LEARNING;

ADVERSE DRUG REACTION (ADRS); ADVERSE DRUG REACTIONS; PERFORMANCE COMPARISON; PHARMACOVIGILANCE; SOCIAL MEDIA; SOCIAL MEDIA PLATFORMS; SUPERVISED CLASSIFICATION; SUPERVISED LEARNING APPROACHES;

PHARMACODYNAMICS;

ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; EMBASE; HUMAN; LEARNING ALGORITHM; MEDLINE; PRIORITY JOURNAL; REVIEW; SCOPUS; SEARCH ENGINE; SOCIAL MEDIA; TASK PERFORMANCE; WEB OF SCIENCE; INTERNET; PUBLIC HEALTH;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; INTERNET; MEDLINE; PHARMACOVIGILANCE; PUBLIC HEALTH; SOCIAL MEDIA;

EID: 84927917741     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2015.02.004     Document Type: Review

References (69)

1. The importance of pharmacovigilance - safety monitoring of medicinal products. World Health Organization, 2002. . http://apps.who.int/medicinedocs/en/d/Js4893e/1.html.
2. Harpaz R., DuMouchel W., Shah N.H., Madigan D., Ryan P., Friedman C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther 2012, 91(3):1010-1021.
3. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998, 279(15):1200-1205.
4. Ahmad S.R. Adverse drug event monitoring at the food and drug administration - your report can make a difference. J Internal Med 2003, 18(1):57-60.
5. Xu R., Wang Q. Large-scale combining signals from both biomedical literature and FDA adverse event reporting system (FAERS) to improve post-marketing drug safety signal detection. BMC Bioinform 2014, 15(17).
6. Gurulingappa H, Fluck J, Hofmann-apitius M, Toldo L. Identification of adverse drug event assertive sentences in medical case reports. In: Proceedings of ECML PKDD 2-11 workshop on knowledge discovery in health care and medicine; 2011.
7. FDA Adverse Event Reporting System (FAERS). . http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/.
8. MedWatch: the FDA safety information and adverse event reporting program. . http://www.fda.gov/Safety/MedWatch/default.htm.
9. Forster A.J., Jennings A., Chow C., Leeder C., van Walraven C. A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc (JAMIA) 2011, 19:31-38.
10. Kumar V. Challenges and future considerations for pharmacovigilance. J Pharmacovigilance 2013, 1(1):1-3.
11. The social life of health information. The Pew Research Center. . http://www.pewinternet.org/2011/05/12/the-social-life-of-health-information-2011/.
12. ying Sylvia Chou W., Hunt Y.M., Beckjord E.B., Moser R.P., Hesse B.W. Social media use in the united states: implications for health communication. J Med Internet Res 2009, 11(4):e48.
13. Online Support Groups and Forums at DailyStrength. . http://www.dailystrength.org.
14. MedHelp Medical Support Communities. . http://www.medhelp.org/forums/list.
15. Corley C.D., Cook D.J., Mikler A.R., Singh K.P. Advances in computational biology 2010, Springer, New York, p. 559-64 [chapter using Web and Social Media for Influenza Surveillance].
16. Kass-Hout T., Alhinnawi H. Social media in public health. Br Med Bull 2013, 108(1):5-24.
17. Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In: Proceedings of the 2010 workshop on biomedical natural language processing; 2010. p. 117-25.
18. Struik L.L., Baskerville N.B. The role of Facebook in crush the crave, a mobile- and social media-based smoking cessation intervention: qualitative framework analysis of posts. J Med Internet Res 2014, 16(7).
19. Hanson C.L., Cannon B., Burton S., Giraud-Carrier C. An exploration of social circles and prescription drug abuse through Twitter. J Med Internet Res 2013, 15(9).
20. Nakhasi A, Passarella RJ, Bell SG, Paul MJ, Dredze M, Provost PJ. Malpractice and malcontent: analysing medical complaints in Twitter. AAAI technical report. Information retrieval and knowledge discovery in biomedical text, Johns Hopkins University; 2012.
21. Sarasohn-Kahn J. The wisdom of patients: health care meets online social media; 2008. . http://www.chcf.org//media/MEDIA%20LIBRARY%20Files/%20PDF/H/PDF%20HealthCareSocialMedia.pdf.
22. Velasco E., Agheneza T., Denecke K., Kirchner G., Eckmanns T. Social media and internet-based data in global systems for public health surveillance: a systematic review. Milbank Quart 2014, 92:7-33.
23. Hartley D.M. Using social media and internet data for public health surveillance: the importance of talking. Milbank Quart 2014, 92:34-39.
24. Stricker B.H., Psaty B.M. Detection, verification, and quantification of adverse drug reactions. BMJ 2004, 329(7456):44-47.
25. Guidance notes on the management of adverse events and product complaints from digital media; 2013. . http://www.abpi.org.uk/our-work/library/guidelines/Pages/safety-data-websites.aspx.
26. Guidance for Industry. Fulfilling regulatory requirements for postmarketing submissions of interactive promotional media for prescription human and animal drugs and biologics; 2014. . http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM381352.pdf.
27. Guidance for Industry. Internet/social media platforms with character space limitations - presenting risk and benefit information for prescription drugs and medical devices; 2014. . http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm401087.pdf.
28. Pan GJD. Adverse event reporting and medication safety considerations: a view from CDER's office of surveillance and epidemiology; May 2013. . http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/UCM352766.pdf.
29. White Paper: Social Media in the Pharmaceutical Industry. . http://www.brandchannel.com/images/papers/522_2011-02_AZ_Social_Media.pdf.
30. Edwards I.R., Lindquist M. Social media and networks in pharmacovigilance: boon or bane. Drug Saf 2011, 34(4):267-271.
31. Franzen W. Can social media benefit drug safety. Drug Saf 2012, 34(9):793.
32. Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf.http://dx.doi.org/10.1007/s40264-014-0218-z. doi:10.1007/s40264-014-0218-z.
33. Abbasi A., Adjeroh D. Social media analytics for smart health. Intell Syst 2014, 60-80.
34. Nikfarjam A, Gonzalez G. Pattern mining for extraction of mentions of adverse drug reactions from user comments. In: Proceedings of the American medical informatics association (AMIA) annual symposium; 2011. p. 1019-26.
35. O'Connor K, Nikfarjam A, Ginn R, Pimpalkhute P, Sarker A, Smith K, et al. Pharmacovigilance on Twitter? Mining tweets for adverse drug reactions. In: Proceedings for the American medical informatics association (AMIA) annual symposium; 2014.
36. Tuarob S., Tucker C.S., Salathe M., Ram N. An ensemble heterogeneous classification methodology for discovering health-related knowledge in social media messages. J Biomed Inform 2014, 49:255-268.
37. Owoputi O, O'Connor B, Dyer C, Gimpel K, Schneider N, Smith NA. Improved part-of-speech tagging for online conversational text with word clusters. In: Proceedings of the NAACL-HLT; 2013. p. 380-90.
38. Ginn R, Pimpalkhute P, Nikfarjam A, Patki A, O'Connor K, Sarker A, et al. Mining Twitter for adverse drug reaction mentions: a corpus and classification benchmark. In: Proceedings of the fourth workshop on building and evaluating resources for health and biomedical text processing; 2014.
39. Patki A, Sarker A, Pimpalkhute P, Nikfarjam A, Ginn R, O'Connor K, et al. Mining adverse drug reaction signals from social media: going beyond extraction. In: Proceedings of BioLinkSig 2014; 2014.
40. Chee BW, Berlin R, Schatz B. Predicting adverse drug events from personal health messages. In: Proceedings of the American medical informatics association (AMIA) annual symposium; 2011. p. 217-26.
41. Sarker A, Gonzalez G. Portable automatic text classification for adverse drug reaction detection via multi-corpus training, J Biomed Inform 2015;53:196-207.
42. Benton A., Ungar L., Hill S., Hennessy S., Mao J., Chung A., et al. Identifying potential adverse effects using the web: a new approach to medical hypothesis generation. J Biomed Inform 2011, 44:989-996.
43. Hadzi-Puric J, Grmusa J. Automatic drug adverse reaction discovery from parenting websites using disproportionality methods. In: IEEE/ACM conference on advances in social networks analysis and mining; 2012. p. 792-7.
44. Yang CC, Yang H, Jiang L, Zhang M. Social media mining for drug safety signal detection. In: Proceedings of the 2012 international workshop on smart health and wellbeing; 2012. p. 33-44.
45. Bian J, Topaloglu U, Yu F. Towards large-scale twitter mining for drug-related adverse events. In: Proceedings of the 2012 international workshop on smart health and wellbeing; 2012. p. 25-32.
46. Liu X, Chen H. AZDrugMiner: an information extraction system for mining patient-reported adverse drug events in online patient forums. In: Proceedings of the 2013 international conference on smart health; 2013. p. 134-50.
47. American Diabetes Association Community. . http://community.diabetes.org.
48. Yang M, Wang X, Kiang M. Identification of consumer adverse drug reaction messages on social media. In: Proceedings of the Pacific Asia conference on information systems (PACIS), no. 193; 2013. . http://aisel.aisnet.org/pacis2013/193.
49. Jiang K., Zheng Y. Mining twitter data for potential drug effects. Adv Data Min Appl 2013, 8346:434-443.
50. Yates A, Goharian N. ADRTrace: detecting expected and unexpected adverse drug reactions from user reviews on social media sites. In: Proceedings of the 35th European conference on advances in information retrieval; 2013. p. 816-9.
51. Ask a Patients. . http://www.askapatient.com.
52. Drugs.com: know more. Be Sure. . http://www.drugs.com.
53. DrugRatingz: find, rate and review drugs and medications. . http://www.drugratingz.com.
54. Yeleswarapu S., Rao A., Joseph T., Saipradeep V.G., Srinivasan R. A pipeline to extract drug-adverse event pairs from multiple data sources. BMC Med Inform Decis Making 2014, 14(13).
55. PatientsLikeMe: live better, together. . http://www.patientslikeme.com.
56. Mediguard: medication monitoring made simple. . http://https://www.mediguard.org.
57. Freifeld C.C., Brownstein J.S., Menone C.M., Bao W., Felice R., Kass-Hout T., et al. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Saf 2014, 37(5):343-350.
58. Segura-Bedmar I, Revert R, Martinez P. Detecting drugs and adverse events from Spanish health social media streams. In: Proceedings of the 5th international workshop on health text mining and information analysis (LOUHI); 2014. p. 106-15.
59. Forumclinic: Programa interactivo para pacientes. . http://https://www.forumclinic.org.
60. Liu X, Liu J, Chen H. Identifying adverse drug events from health social media: a case study on heart disease discussion forums. In: Proceedings of the international conference on smart health (ICSH); 2014. p. 25-36.
61. Yang C.C., Yang H., Jiang L. Postmarketing drug safety surveillance using publicly available health-consumer-contributed content in social media. ACM Trans Manage Inform Syst 2014, 5(1):2:1-2:21. 10.1145/2576233.
62. Sampathkumar H., Wen Chen X., Luo B. Mining adverse drug reactions from online healthcare forums using hidden Markov model. BMC Med Inform Decis Making 2014, 14(91).
63. The premier community to talk about health. . http://www.medications.com/.
64. SteadyHealth - ask, share, contribute. . http://www.steadyhealth.com/.
65. Nikfarjam A., Sarker A., O'Connor K., Ginn R., Gonzalez G. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features. J Am Med Inform Assoc 2015, 22(2).
66. Gurulingappa H., Mateen-Rajput A., Toldo L. Extraction of potential adverse drug event from medical case reports. J Biomed Semantics 2012, 3(15).
67. Aronson AR. Effective mapping of biomedical text to the UMLS metathesaurus: the metamap program. In: Proceedings of the American medical informatics association annual symposium; 2001. p. 17-21.
68. Piatetsky-Shapiro G. Knowledge discovery in databases 1991, AAAI/MIT Press, Cambridge, MA, [chapter Discovery, analysis, and presentation of strong rules].
69. Pimpalkhute P, Patki A, Gonzalez G. Phonetic spelling filter for keyword selection in drug mention mining from social media. In: Proceedings of the American medical informatics association (AMIA) annual symposium; 2013.